This significant downturn reflects a staggering 1-year change, with the company's stock value eroding by -84.83%. Investors have watched with concern as Omega, known for its innovative approaches in ...

K filing with the Securities and Exchange Commission that Christian S. Schade has resigned as Chair and a member of the Board of Directors. Schade also stepped down from his positions on the ...

Michelle C. Werner has resigned from Omega Therapeutics’ Board of Directors and the Nominating and Corporate Governance Committee, effective immediately. The company has also received a non ...

CAMBRIDGE, MA – Omega Therapeutics, Inc. (NASDAQ:OMGA), a biotechnology firm specializing in biological products, reported today that Christian S. Schade has resigned from his positions as Chair and ...

Omega Therapeutics ( (OMGA)) has shared an announcement. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with ...

Investing.com - Omega Therapeutics (NASDAQ: OMGA) reported third quarter EPS of $-0.300, $0.02 worse than the analyst estimate of $-0.280. Revenue for the quarter came in at... ByInvesting.com ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...